Navigation Links
Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
Date:5/14/2013

THOD OF USING ZINC OXIDE QUANTUMDOTS TO MARK ANTIBODY 88EUROPEAN REGISTERED PATENTS 88TABLE 39 SAMPLE OF EUROPEAN IMMUNOASSAY PATENTS, 2000-2012 89JAPANESE PATENT TRENDS 89TABLE 40 JAPANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 90TABLE 41 JAPANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 90JAPANESE PATENT SHARES BY ASSIGNEE 90TABLE 42 JAPANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OFPATENTS/%) 90SAMPLE ABSTRACTS OF JAPANESE PATENT ABSTRACTS 91ENZYME IMMUNOASSAY USING ENZYME LABELED ANTIBODY 91FLUORESCENCE IMMUNOASSAY 92FLUORESCENT POLYMER MICROPARTICLE, ITS PRODUCTION, ANDREAGENT AND METHOD FOR FLUORO IMMUNOASSAY UTILIZING THE SAME 92JAPANESE PATENT REGISTERED PATENTS 93TABLE 43 SAMPLE OF JAPANESE IMMUNOASSAY PATENTS, 2000-2012 93CHINESE PATENT TRENDS 93TABLE 44 CHINESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 94TABLE 45 CHINESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 94CHINESE PATENT SHARES BY HOLDER 95TABLE 46 CHINESE PATENT SHARES BY PATENT HOLDER, 2000-2012 (NO. OFPATENTS/%) 95SAMPLE ABSTRACTS OF CHINESE PATENT ABSTRACTS 96IMMUNOASSAY AND DIAGNOSTIC REAGENT FOR MALARIA 96ENZYME IMMUNOASSAY KIT FOR COXSACKIE VIRUS B ANTIGEN AND ITSPREPARING PROCESS 97VISUAL FLUORESCENCE IMMUNOASSAY METHOD FOR DETERMININGBIOLOGICAL ACTIVE SUBSTANCE 97CHINESE PATENTS 97TABLE 47 SAMPLE OF CHINESE IMMUNOASSAY PATENTS, 2000-2012 98TAIWANESE PATENT TRENDS 98TABLE 48 TAIWANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 99TABLE 49 TAIWANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 99TABLE 50 TAIWANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OFPATENTS/%) 100SAMPLE ABSTRACTS OF TAIWAN PATENTS 100IMMUNOASSAY METHOD FOR DETERMINING GLYCOSYLATED PROTEIN ANDTEST LIQUID THEREOF 100CARRIER-ENZYME-PROTEIN COMPLEX AND IMMUNOASSAY KITCOMPRISING THE SAME 100TAIWANESE REGISTERED PATENTS 101TABLE 51 SAMPLE OF TAIWANESE IMMUNOASSAY PA
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
2. AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
3. Patient Safety Technologies Reports First Quarter 2013 Results
4. Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
5. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
6. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
7. Blue Belt Technologies maakt vorming van Wetenschappelijke Heup Adviesraad bekend voor ontwikkeling van volgende NavioPFS-toepassing voor femoroacetabulair impingement
8. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
9. Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
10. Update to Shareholders on Dividend Payment: Medisafe 1 Technologies Corporation Files Corporate Action Form with FINRA for the Dividend Distribution to its Shareholders
11. Flexpoint Announces Universal Settlement Involving the Medical Bed and Related Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 MiMedx Group, ... developer, processor and marketer of patent protected regenerative ... announced today that it has entered into a ... MiMedx will provide its dehydrated human amnion/chorion membrane ... non- exclusively on a private label basis. ...
(Date:9/18/2014)... 18, 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has removed the ... PEGPH20 in SWOG,s ongoing Phase 1b/2 clinical trial ... investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in ... with metastatic pancreatic adenocarcinoma.  The study will resume ...
(Date:9/18/2014)... -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company ... announced today that it has appointed Mr. Christopher ... of Clinical Development. During his extensive career ... successful global clinical operations teams, in the US and ... development of numerous therapeutics and diagnostics across a broad ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2
... (ASX: PGL; Nasdaq: PGLA) today announced additional,data from the ... this,year. This data was presented at the 58th Annual ... Diseases in Boston, USA(1). As the Phase 2 ... data analysis described in this presentation was performed to,evaluate ...
... overall rate of sustained virologic response in ... long-acting interferons in ... Albuferon non-responder study presented at the, Annual Meeting of the American Association for the Study ... ...
Cached Medicine Technology:Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6
(Date:9/18/2014)... (PRWEB) September 18, 2014 It is almost ... sprint or walk for healthier and happier kids. The ... participate in the 4th Annual Miami Children’s Hospital 5K Run/Walk. ... http://www.hyundaihopeonwheels.org , The 5K will take place ... will be outside of Coral Gables City Hall located at ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Clinical trial ... data on the Edema clinical trial scenario. This report ... trials on Edema. It includes an overview of the ... site of trial conduction across the globe. The databook ... their phase, trial status, prominence of the sponsors and ...
(Date:9/18/2014)... PA (PRWEB) September 18, 2014 ... announces the launch of Good Neighbor Pharmacy University, ... access information that will educate and empower pharmacy ... “As the healthcare industry continues to evolve, Good ... as we deliver resources and tools to help ...
(Date:9/18/2014)... September 18, 2014 CD-adapco, the largest ... software, today announced its new partnership with Ben Ainslie ... CD-adapco simulation tool, STAR-CCM+® in the design of its ... participation in the 35th America’s Cup taking place in ... the America’s Cup is sustainability, the set of restrictive ...
(Date:9/18/2014)... more vegetables and drink less sugar, according to a ... it,s still not enough, the study goes on to ... comes to eating healthier at school , The research ... status, may inform a child,s diet. , The study ... education were 85 per cent more likely to eat ...
Breaking Medicine News(10 mins):Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2Health News:Ben Ainslie Racing Using STAR-CCM+ Simulation Software to Design 35th America’s Cup Racing Boat 2Health News:Kids eat better if their parents went to college 2
... a study published in the recent issue of Annals ... exercise //as preconditions to prevent and control diabetes type ... cost effective to control diabetes through rigorous exercise and ... diabetes reduces the body’s ability to store calories, resulting ...
... at the annual meeting of the American Academy of Orthopedic ... back pain may be the result of several problems other ... restrict the effect of a surgery. The study that had ... National Spine Network, US, said that patients who had other ...
... 100 patients at an ear , nose and throat clinic ... snoring // shouldn't expect to receive a diagnosis of obstructive ... examination alone instead an overnight sleep testing needs to be ... ,For the study, physicians evaluated the patients with a ...
... now that after delivery depressions, that had plagued new mothers all ... the delivery. As a result of this belief, many pregnant women ... new study that comes in the recent issue of British Medical ... to Deirdre Murphy of Dundee University, who had led the team ...
... twins and their mothers to see if there was a ... // of life and children's antisocial behavior by age 7 ... have increased problems with conduct and more antisocial behavior . ... the twins' birth and the likeliness of antisocial behavior in ...
... to treat agitation in patients with Alzheimer's or dementia, ... findings of a recent study .// ,For ... Twenty-six of the patients received quetiapine (an antipsychotic also ... also known as Exelon), and 29 received a placebo. ...
Cached Medicine News:
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: